Table 3.
ELISA Kit | Optimized ELISA cut-off | AUC (95% CI) |
% Relative sensitivity (95% CI) | % Relative specificity (95% CI) | PPV % (95% CI) | NPV % (95% CI) |
---|---|---|---|---|---|---|
TOXO-MS | ≥ 36.2 S/P% | 0.97 (0.94–1.00) | 94.5 (87.6–98.2) | 97.9 (92.6–99.7) | 97.7 (92.0–99.3) | 94.9 (88.5–99.4) |
NCS-MS | ≥ 34.9 S/P% | 0.96 (0.91–1.01) | 89.3 (71.8–97.7) | 100.0 (95.4–NaN) | 100 (86.9–100) | 96.3 (88.8–NaN) |
NCC | ≤ 78.6 S/N% | 0.97 (0.92–1.01) | 92.9 (76.5–99.1) | 97.4 (91.0–99.7) | 92.9 (77.7–99.1) | 97.4 (90.5–99.7) |
Notes: Relative accuracies of commercial ELISA kits used for detection of antibodies against Toxoplasma gondii (i.e. ID Screen® Toxoplasmosis Indirect ELISA) and N. caninum (i.e. ID Screen® Neospora caninum Indirect Multi-species ELISA and ID Screen® Neospora caninum Competition ELISA) in South American camelids, in relation to N. caninum and T. gondii immunoblots
Abbreviations: TOXO-MS, ID Screen® Toxoplasmosis Indirect; NCS-MS, ID Screen® Neospora caninum Indirect Multi-species ELISA; NCC, ID Screen® Neospora caninum Competition; S/P%, sample-to-positive ratio; S/N%, competition percentage; AUC, area under the ROC curve; CI, confidence interval; TP, true positives; FP, false positives; TN, true negatives; FN, false negatives; PPV, positive predictive value; NPV, negative predictive value; NaN, upper limit of the confidence interval could not be computed